The contribution of germline DNA damage response mutations on prostate cancer risk and prognosis: A UK Biobank whole-exome analysis.

被引：0

作者：

Camacho, Niedzica ^{[1
]}

Matakidou, Athena ^{[1
]}

机构：

[1] AstraZeneca, Cambridge, England

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 06期

关键词：

D O I：

10.1200/JCO.2021.39.6_suppl.67

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：1

共 50 条

[31] Protein-truncating and rare missense variants in ATM and CHEK2 and associations with cancer in UK Biobank whole-exome sequence data
Mukhtar, Toqir K.
Wilcox, Naomi
Dennis, Joe
Yang, Xin
Naven, Marc
Mavaddat, Nasim
Perry, John R. B.
Gardner, Eugene
Easton, Douglas F.
JOURNAL OF MEDICAL GENETICS, 2024,
[32] Characteristics of germline DNA damage response gene mutations in ovarian cancer in Southwest China
Fu, Kaiyu
Li, Qingli
Wang, Jie
Zhang, Mengpei
Yan, Xinyu
Li, Kemin
Song, Liang
Zhong, Lan
Ma, Yu
Chen, Jinghong
Zeng, Jing
Wang, Danqing
Shao, Di
Zhu, Shida
Yin, Rutie
SCIENTIFIC REPORTS, 2024, 14 (01)
[33] Characteristics of germline DNA damage response gene mutations in ovarian cancer in Southwest China
Kaiyu Fu
Qingli Li
Jie Wang
Mengpei Zhang
Xinyu Yan
Kemin Li
Liang Song
Lan Zhong
Yu Ma
Jinghong Chen
Jing Zeng
Danqing Wang
Di Shao
Shida Zhu
Rutie Yin
Scientific Reports, 14
[34] A whole-exome case-control association study to characterize the contribution of rare coding variation to pancreatic cancer risk
Yu, Yao
Chang, Kyle
Chen, Jiun-Sheng
Bohlender, Ryan J.
Fowler, Jerry
Zhang, Di
Huang, Maosheng
Chang, Ping
Li, Yanan
Wong, Justin
Wang, Huamin
Gu, Jian
Wu, Xifeng
Schildkraut, Joellen
Cannon-Albright, Lisa
Ye, Yuanqing
Zhao, Hua
Hildebrandt, Michelle A. T.
Permuth, Jennifer B.
Li, Donghui
Scheet, Paul
Huff, Chad D.
HUMAN GENETICS AND GENOMICS ADVANCES, 2022, 3 (01):
[35] A literature review of whole exome and genome sequencing population studies for identifying novel germline mutations in relation to cancer risk
Barajas, Rolando
Hoover, Elise
Clyne, Mindy
Lam, Tram
Mechanic, Leah
Goldstein, Alisa
Gillanders, Elizabeth
Rotunno, Melissa
CANCER RESEARCH, 2019, 79 (13)
[36] Inherited Germline Variants in Urinary Tract Cancer: A Multicenter Whole-Exome Sequencing Analysis and Correlation With Clinical Features and Tumor Genomics
Kohlmann, Wendy
Nix, David A.
Pauley, Kristen
Greenberg, Samantha
Atkinson, Aaron
Boucher, Kenneth M.
Kolesar, Jill
Singer, Eric A.
Edge, Stephen B.
Churchman, Michelle L.
Graham, Laura
Salhia, Bodour
Sanchez, Alejandro
Zakharia, Yousef
Nepple, Kenneth G.
Schneider, Bryan P.
Byrne, Lindsey
Jain, Rohit K.
Chahoud, Jad
Feng, Bing-Jian
Gupta, Sumati
JCO PRECISION ONCOLOGY, 2024, 8
[37] Predicting Cancer Risk from Germline Whole-exome Sequencing Data Using a Novel Context-based Variant Aggregation Approach
Guan, Zoe
Begg, Colin B.
Shen, Ronglai
CANCER RESEARCH COMMUNICATIONS, 2023, 3 (03): : 483 - 488
[38] Tumor testing in men with prostate cancer to predict for germline DNA-damage repair mutations.
Carlo, Maria Isabel
Kemel, Yelena
Breen, Kelsey
Cadoo, Karen Anne
Walsh, Michael Francis
Abida, Wassim
Autio, Karen A.
Danila, Daniel Costin
Kampel, Lewis J.
Morris, Michael J.
Rathkopf, Dana E.
Slovin, Susan F.
Solit, David B.
Offit, Kenneth
Stadler, Zsofia Kinga
Scher, Howard I.
Robson, Mark E.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
[39] A systematic review of the prevalence of DNA damage response gene mutations in prostate cancer
Lang, Shona H.
Swift, Stephanie L.
White, Heath
Misso, Kate
Kleijnen, Jos
Quek, Ruben G. W.
INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 55 (03) : 597 - 616
[40] Germline DNA repair gene mutations in a cohort of high-risk prostate cancer patients
Galego Carro, Javier Manuel
Santamarina, Marta
Fuentes, Olivia
Aguado-Barrera, Miguel E.
Perez, Carlos
Lopez, Carlos
Crujeiras, Ana
Gomez-Caamano, Antonio
Vega, Ana
EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 251 - 251

← 1 2 3 4 5 →